CHRISTOPHER GREEN: Open Payments
NPI 1417953712 · MARYSVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 23 payments from 10 companies in 2025. Trend: 2023 $211 · 2024 $296 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $137 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| GENZYME CORPORATION | 2 | $40 |
| Verona Pharma, Inc. | 2 | $39 |
| Insulet Corporation | 1 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Amgen Inc. | 1 | $18 |
Products named: Wegovy, LEQVIO, NUCALA, Ozempic, DUPIXENT, Ohtuvayre, Omnipod, ONPATTRO.
Industry payments across OH — which companies pay providers there.
